CANC ETF (Tema Oncology ETF) is managed by Tema Global Limited with $165.8M in net assets. CANC expense ratio is 0.75%, holding 57 positions across sectors including Health Care, Unknown, Other. Inception date: 2023-08-15.

CANC performance shows a YTD return of 3.25%. The 1-year return is 39.35%. CANC dividend yield stands at 0.05%, paid annually.

CANC top holdings include Revolution Medicines Inc Ser C Pc Pp (7.3%), Novartis Ag (4.6%), Eli Lilly & Co (4.5%), AstraZeneca PLC (4.3%), Bridgebio Pharma Inc (4.3%). View all CANC holdings, sector breakdown, or dividend history.

CANC can be compared against other funds using the overlap calculator or side-by-side comparison tool. CANC alternatives are available via the screener, along with tax-loss harvesting opportunities.